JP2001299280A - Calcium supplement including polysaccharide having carboxyl group and calcium-enriched agent - Google Patents
Calcium supplement including polysaccharide having carboxyl group and calcium-enriched agentInfo
- Publication number
- JP2001299280A JP2001299280A JP2000119045A JP2000119045A JP2001299280A JP 2001299280 A JP2001299280 A JP 2001299280A JP 2000119045 A JP2000119045 A JP 2000119045A JP 2000119045 A JP2000119045 A JP 2000119045A JP 2001299280 A JP2001299280 A JP 2001299280A
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- calcium compound
- polysaccharide
- water
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 52
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 52
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 52
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 title claims abstract description 34
- 229940069978 calcium supplement Drugs 0.000 title claims abstract description 8
- 239000011575 calcium Substances 0.000 title claims description 45
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims description 42
- 229910052791 calcium Inorganic materials 0.000 title claims description 40
- 239000003795 chemical substances by application Substances 0.000 title description 4
- 229940043430 calcium compound Drugs 0.000 claims abstract description 83
- 150000001674 calcium compounds Chemical class 0.000 claims abstract description 83
- 239000006185 dispersion Substances 0.000 claims abstract description 67
- 239000002245 particle Substances 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000010419 fine particle Substances 0.000 claims abstract description 27
- 239000001506 calcium phosphate Substances 0.000 claims description 41
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 41
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 41
- 235000011010 calcium phosphates Nutrition 0.000 claims description 40
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 28
- 239000012744 reinforcing agent Substances 0.000 claims description 25
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 21
- 239000002131 composite material Substances 0.000 claims description 19
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 8
- 239000000920 calcium hydroxide Substances 0.000 claims description 8
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 238000000926 separation method Methods 0.000 abstract description 10
- 230000002411 adverse Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 50
- 229960001714 calcium phosphate Drugs 0.000 description 37
- 239000000243 solution Substances 0.000 description 37
- 229960005069 calcium Drugs 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 21
- 235000013305 food Nutrition 0.000 description 18
- 239000007864 aqueous solution Substances 0.000 description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 230000008859 change Effects 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 235000011007 phosphoric acid Nutrition 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 239000010408 film Substances 0.000 description 11
- 238000004062 sedimentation Methods 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 230000002194 synthesizing effect Effects 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 8
- 239000013049 sediment Substances 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 7
- 230000002776 aggregation Effects 0.000 description 7
- 235000011116 calcium hydroxide Nutrition 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- -1 Alkali metal salts Chemical class 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 235000010216 calcium carbonate Nutrition 0.000 description 5
- 229960004106 citric acid Drugs 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 229910052586 apatite Inorganic materials 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000021056 liquid food Nutrition 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 238000010979 pH adjustment Methods 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 235000021055 solid food Nutrition 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 235000011167 hydrochloric acid Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000019691 monocalcium phosphate Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000011164 primary particle Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 240000004178 Anthoxanthum odoratum Species 0.000 description 1
- 235000014251 Anthoxanthum odoratum Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- FAYYUXPSKDFLEC-UHFFFAOYSA-L calcium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [Ca+2].[O-]S([O-])(=O)=S FAYYUXPSKDFLEC-UHFFFAOYSA-L 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229910052589 chlorapatite Inorganic materials 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- UZLGHNUASUZUOR-UHFFFAOYSA-L dipotassium;3-carboxy-3-hydroxypentanedioate Chemical compound [K+].[K+].OC(=O)CC(O)(C([O-])=O)CC([O-])=O UZLGHNUASUZUOR-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000007983 food acid Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012760 heat stabilizer Substances 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 235000019837 monoammonium phosphate Nutrition 0.000 description 1
- 239000002444 monopotassium citrate Substances 0.000 description 1
- 235000015861 monopotassium citrate Nutrition 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- WKZJASQVARUVAW-UHFFFAOYSA-M potassium;hydron;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].OC(=O)CC(O)(C(O)=O)CC([O-])=O WKZJASQVARUVAW-UHFFFAOYSA-M 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000015870 tripotassium citrate Nutrition 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000019263 trisodium citrate Nutrition 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は分子内にカルボキシ
ル基を含有する多糖類を用いることにより水への分散安
定性を改良した、水に難溶なカルシウム化合物を微粒子
状に分散したカルシウム補強剤およびその製造方法に関
する。さらには、クエン酸存在下に水に難溶なカルシウ
ム化合物を合成することを特徴とした、分散安定性に優
れたクエン酸/カルシウム化合物複合体からなるカルシ
ウム補強剤およびその製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a calcium reinforcing agent in which a poorly water-soluble calcium compound is dispersed in fine particles in which the dispersion stability in water is improved by using a polysaccharide containing a carboxyl group in the molecule. And its manufacturing method. Further, the present invention relates to a calcium reinforcing agent comprising a citric acid / calcium compound composite having excellent dispersion stability, which is characterized by synthesizing a calcium compound hardly soluble in water in the presence of citric acid, and a method for producing the same.
【0002】[0002]
【従来の技術】日本人が1日に必要とされるカルシウム
量は600mgであるとされているが、厚生省が実施し
ている国民栄養調査によると、調査開始以来カルシウム
摂取量はその所要量を満たしたことがない。その理由に
は、日本の土壌中に含まれるカルシウムが少ない地域的
な背景や、食文化の違い、および食生活の変化などが指
摘されている。カルシウムを所要量摂取するにはカルシ
ウムに富む食品を意識的に摂取すれば問題ないのである
が、そこが出来ないところにこの問題の本質がある。2. Description of the Related Art It is said that the amount of calcium required by Japanese people per day is 600 mg. However, according to the National Nutrition Survey conducted by the Ministry of Health and Welfare, calcium intake has been Never met. It is pointed out that the reasons for this are regional background of low calcium in Japanese soil, differences in food culture, and changes in dietary habits. There is no problem if you consciously consume foods rich in calcium to get the required amount of calcium, but the essence of this problem is that you cannot do it.
【0003】この問題を解決するために、通常カルシウ
ムをほとんど含まない食品にカルシウムを添加して不足
しがちなカルシウムを補給できるようにする方法があ
る。この方法では、天然物由来あるいは人工的に合成さ
れた各種のカルシウム剤が知られている。天然物素材と
しては卵殻や貝殻、動物の骨などがあるが、これらの天
然物素材は基本的に水に不溶であるため、飲料や液状食
品に添加する場合、舌触りに違和感ないように微細に粉
砕したスラリーとした状態で使用される。しかしなが
ら、粉砕可能な粒子の大きさは数ミクロンのレベルが限
界であり、食感に問題はないものの経時で沈降を起こす
ため、長期保存される食品には使用が困難であるし、短
期保存食品に対しても使用が制限される問題がある。こ
のような沈降の問題を解決する方法として、特開平9−
289877号公報に500nm以下のヒドロキシアパ
タイト(リン酸カルシウムの一種)を合成し、これをク
エン酸またはその塩の含有液、カゼインやアルブミンな
どの蛋白質、カゼインホスホペプチド等のペプチドを用
いて表面処理する方法が開示されている。この方法によ
ると沈降を抑制する効果は認められるものの、その効果
は十分だとは言い難く、また食品へ添加した際に食味を
変化させる可能性があるため、さらに分散性が改良され
て食味に影響を及ぼさないカルシウム補強剤が望まれて
いた。[0003] In order to solve this problem, there is a method in which calcium is added to a food containing almost no calcium so that calcium which tends to be insufficient can be supplied. In this method, various calcium agents derived from natural products or artificially synthesized are known. Natural materials include eggshells, shells, and animal bones.Since these natural materials are basically insoluble in water, when added to beverages and liquid foods, they must be finely sized so that they do not feel uncomfortable to the touch. Used in the form of a pulverized slurry. However, the size of crushable particles is limited to several microns, and although there is no problem in texture, sedimentation occurs over time, making it difficult to use for long-term stored foods and short-term stored foods. There is also a problem that the use is restricted. As a method for solving such a problem of sedimentation, Japanese Patent Laid-Open No.
No. 289877 discloses a method of synthesizing a hydroxyapatite (a kind of calcium phosphate) of 500 nm or less and treating the surface with a solution containing citric acid or a salt thereof, a protein such as casein or albumin, or a peptide such as casein phosphopeptide. It has been disclosed. According to this method, although the effect of suppressing sedimentation is recognized, its effect is hardly sufficient, and since it may change the taste when added to food, the dispersibility is further improved and the taste is improved. A calcium filler that has no effect was desired.
【0004】[0004]
【発明が解決しようとする課題】本発明の目的は、ナノ
メートルオーダーのカルシウム化合物微粒子が凝集ある
いは分離・沈降等を起こさず均一に分散し、食味に影響
を及ぼすことのないカルボキシル基を含有する多糖類/
カルシウム化合物複合体を含有するカルシウム補強剤を
提供することにある。さらには、分散安定性を改良した
クエン酸塩/カルシウム化合物複合体を含有するカルシ
ウム補強剤を提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a calcium compound fine particle of the order of nanometers which is uniformly dispersed without causing aggregation, separation, sedimentation, etc., and contains a carboxyl group which does not affect the taste. Polysaccharide /
An object of the present invention is to provide a calcium reinforcing agent containing a calcium compound complex. Another object of the present invention is to provide a calcium reinforcing agent containing a citrate / calcium compound composite having improved dispersion stability.
【0005】[0005]
【課題を解決するための手段】本発明者らは前述の課題
を解決するために鋭意検討を重ねた結果、カルボキシル
基を含有する多糖類を用いることにより、水に難溶なカ
ルシウム化合物微粒子が安定に分散することを見出し本
発明に至った。また、この複合体を安定化する方法を検
討する中で、カルボキシル基を有する多糖類の存在下で
水に難溶なカルシウム化合物を合成するとカルシウム化
合物の粒子形態が変化し、分散性が大幅に改善されるこ
とを見出した。これを従来分散安定性に効果があると報
告されていたクエン酸塩に適用することにより、単に混
合して表面処理を行ったものに比べて飛躍的に分散安定
性が向上することを見出した。Means for Solving the Problems The inventors of the present invention have made intensive studies to solve the above-mentioned problems, and as a result, by using a polysaccharide containing a carboxyl group, calcium compound fine particles which are hardly soluble in water can be obtained. The present inventors have found that they are stably dispersed, leading to the present invention. In addition, while studying a method of stabilizing this complex, when a calcium compound that is hardly soluble in water is synthesized in the presence of a polysaccharide having a carboxyl group, the particle morphology of the calcium compound changes, and the dispersibility greatly increases. It was found to be improved. By applying this to citrate, which was conventionally reported to have an effect on dispersion stability, it was found that the dispersion stability was dramatically improved compared to the case of simply mixing and surface-treating. .
【0006】すなわち本発明は、(1)分子内にカルボキ
シル基を含有する多糖類と、粒径500nm以下の水に
難溶なカルシウム化合物微粒子とを、重量比10:90
〜99.9:0.1の範囲で含有する多糖類/カルシウ
ム化合物複合体を含有することを特徴とするカルシウム
補強剤、(2)分子内にカルボキシル基を含有する多糖類
の水系媒体中に粒径500nm以下の水に難溶なカルシ
ウム化合物微粒子を分散してなる、分散安定性に優れる
多糖類/カルシウム化合物複合体分散溶液を含有するこ
とを特徴とする(1)に記載のカルシウム補強剤、(3)
水に難溶なカルシウム化合物が炭酸カルシウムまたはリ
ン酸カルシウムであることを特徴とする(1)または
(2)に記載のカルシウム補強剤、(4)リン酸カルシウ
ムが水酸化カルシウムとリン酸を反応して製造されるも
のであることを特徴とする(3)に記載のカルシウム補
強剤、(5)多糖類/カルシウム化合物複合体がカルボキ
シル基を含有する多糖類存在下にカルシウム化合物を製
造して得られるものであることを特徴とする、(1)〜
(4)のいずれかに記載のカルシウム補強剤、(6)カル
ボキシル基を含有する多糖類存在下に、カルシウム化合
物を製造することを特徴とする、(1)〜(4)のいず
れかに記載のカルシウム補強剤の製造方法、(7)クエン
酸塩の水系媒体中に粒径500nm以下の水に難溶なカ
ルシウム化合物微粒子を分散してなる、分散安定性に優
れるクエン酸塩/カルシウム化合物複合体分散溶液を含
有するものであって、該分散溶液がクエン酸塩存在下に
カルシウム化合物を製造して得られるものであることを
特徴とする、クエン酸塩/カルシウム化合物複合体を含
有するカルシウム補強剤、(8)クエン酸塩存在下にカル
シウム化合物を製造することを特徴とする、(7)に記
載のカルシウム補強剤の製造方法、である。That is, the present invention provides (1) a polysaccharide having a carboxyl group in a molecule thereof and water-soluble calcium compound fine particles having a particle diameter of 500 nm or less in a weight ratio of 10:90.
9999.9: a calcium reinforcing agent characterized by containing a polysaccharide / calcium compound complex containing in the range of 0.1; (2) in a water-based medium of a polysaccharide containing a carboxyl group in a molecule; (1) The calcium reinforcing agent according to (1), which contains a dispersion solution of a polysaccharide / calcium compound complex excellent in dispersion stability, which is obtained by dispersing calcium compound fine particles having a particle diameter of 500 nm or less and is insoluble in water. , (3)
The calcium compound insoluble in water is calcium carbonate or calcium phosphate, wherein the calcium reinforcing agent according to (1) or (2), and (4) calcium phosphate is produced by reacting calcium hydroxide with phosphoric acid. (5) The calcium reinforcing agent according to (3), wherein the polysaccharide / calcium compound complex is obtained by producing a calcium compound in the presence of a carboxyl group-containing polysaccharide. (1)-
(6) The calcium reinforcing agent according to any one of (1) to (4), wherein the calcium compound is produced in the presence of a carboxyl group-containing polysaccharide. (7) A citrate / calcium compound composite having excellent dispersion stability, wherein finely dispersed calcium compound fine particles having a particle diameter of 500 nm or less are dispersed in an aqueous medium of citrate. Calcium containing a citrate / calcium compound complex, characterized by containing a body dispersion solution, wherein the dispersion solution is obtained by producing a calcium compound in the presence of citrate. (8) The method for producing a calcium reinforcing agent according to (7), wherein the calcium compound is produced in the presence of a citrate.
【0007】[0007]
【発明の実施の形態】本発明のカルシウム補強剤は、分
子内にカルボキシル基を含有する多糖類またはクエン酸
塩と、粒径500nm以下の水に難溶なカルシウム化合
物微粒子とを、重量比10:90〜99.9:0.1の
範囲で含有する多糖類またはクエン酸塩/カルシウム化
合物複合体を含有することを特徴とするものである。BEST MODE FOR CARRYING OUT THE INVENTION The calcium reinforcing agent of the present invention comprises a polysaccharide or a citrate having a carboxyl group in the molecule and water-insoluble calcium compound fine particles having a particle size of 500 nm or less in a weight ratio of 10%. : 90 to 99.9: 0.1, characterized by containing a polysaccharide or a citrate / calcium compound complex.
【0008】本発明で使用されるカルボキシル基を含有
する多糖類は、天然由来のものと天然高分子材料を変性
したもの(半合成高分子化合物)が含まれる。天然由来
のカルボキシル基を含有する多糖類はグルクロン酸、ガ
ラクツロン酸、マンヌロン酸などのウロン酸を分子内に
持つ化合物であり、アラビアゴム、アルギン酸ナトリウ
ム、ペクチン、コンドロイチン硫酸ナトリウム、ヒアル
ロン酸ナトリウム、ヘパリンなどが例示される。半合成
高分子化合物は、カルボキシメチルセルロースナトリウ
ム、カルボキシメチルキチンナトリウム、カルボキシメ
チルデンプンナトリウムなどの天然の多糖類を変性した
ものや、でんぷんやセルロース等の多糖類にアクリル酸
をグラフト共重合したものなどがあげられる。これらの
多糖類に含まれるカルボキシル基は通常ナトリウムやカ
リウムなどのアルカリ金属の塩となっていることが好ま
しい。カルボキシル基は完全に塩型になっている必要は
なく、塩酸、硫酸、リン酸のような無機酸、あるいは食
添用に使用可能なクエン酸、フマル酸、リンゴ酸、酢酸
などの有機酸を添加して水溶液のpHを調整することに
より、部分的に酸型として存在するものがあっても問題
ない。The carboxyl group-containing polysaccharide used in the present invention includes those derived from nature and those obtained by modifying natural polymer materials (semi-synthetic polymer compounds). Polysaccharides containing a carboxyl group derived from nature are compounds having uronic acids such as glucuronic acid, galacturonic acid and mannuronic acid in the molecule, gum arabic, sodium alginate, pectin, sodium chondroitin sulfate, sodium hyaluronate, heparin, etc. Is exemplified. Semi-synthetic polymer compounds include those obtained by modifying natural polysaccharides such as sodium carboxymethylcellulose, sodium carboxymethyl chitin, and sodium carboxymethyl starch, and those obtained by graft copolymerization of acrylic acid with polysaccharides such as starch and cellulose. can give. It is preferable that the carboxyl group contained in these polysaccharides is usually a salt of an alkali metal such as sodium or potassium. The carboxyl group does not need to be completely in the form of a salt, and may be an inorganic acid such as hydrochloric acid, sulfuric acid, or phosphoric acid, or an organic acid such as citric acid, fumaric acid, malic acid, or acetic acid that can be used for food addition. By adding and adjusting the pH of the aqueous solution, there is no problem even if some exist as an acid form.
【0009】また、本発明で使用されるクエン酸塩は、
クエン酸一ナトリウム、クエン酸二ナトリウム、クエン
酸三ナトリウム、クエン酸一カリウム、クエン酸二カリ
ウム、クエン酸三カリウムなどのアルカリ金属塩が好適
に使用されるが、前述の無機酸または有機酸、あるいは
水酸化ナトリウムや水酸化カリウムのようなアルカリを
添加して水溶液のpHを調整することにより中和度を種
々変えたものを使っても良い。The citrate used in the present invention is:
Alkali metal salts such as monosodium citrate, disodium citrate, trisodium citrate, monopotassium citrate, dipotassium citrate, and tripotassium citrate are preferably used, and the inorganic or organic acids described above. Alternatively, those having various degrees of neutralization by adding an alkali such as sodium hydroxide or potassium hydroxide to adjust the pH of the aqueous solution may be used.
【0010】本発明の水に難溶なカルシウム化合物微粒
子は、粒径500nm以下であれば制限はないが、食品
として体内に摂取されることを考慮すると、天然のカル
シウム源として利用されるリン酸カルシウムまたは炭酸
カルシウムが好ましい。The water-insoluble calcium compound fine particles of the present invention are not limited as long as they have a particle size of 500 nm or less. However, considering that they are ingested into the body as foods, calcium phosphate or calcium phosphate used as a natural calcium source is used. Calcium carbonate is preferred.
【0011】本発明において多糖類(またはクエン酸
塩)/カルシウム化合物複合体は、前記したカルボキシ
ル基を含有する多糖類(またはクエン酸塩)とカルシウ
ム化合物微粒子とが重量比10:90〜99.9:0.
1、好ましくは15:85〜99.5:0.5、さらに
好ましくは20:80〜99:1の範囲のものである。
カルシウム化合物の量が0.1%より少ないとカルシウ
ム化合物を添加する効果が乏しく、90%を越えると分
散安定性が不良で沈降、分離を起こしやすくなり、均一
な分散溶液を形成できなくなるため好ましくない。In the present invention, the polysaccharide (or citrate) / calcium compound complex comprises the above-mentioned carboxyl group-containing polysaccharide (or citrate) and calcium compound fine particles in a weight ratio of 10:90 to 99.99. 9: 0.
1, preferably 15:85 to 99.5: 0.5, more preferably 20:80 to 99: 1.
If the amount of the calcium compound is less than 0.1%, the effect of adding the calcium compound is poor, and if it exceeds 90%, the dispersion stability is poor, sedimentation and separation are likely to occur, and a uniform dispersion solution cannot be formed. Absent.
【0012】カルシウム化合物微粒子の合成方法として
は、液相合成法が好ましい。いわゆる沈殿法と称される
方法であり、水に可溶あるいは難溶なカルシウム化合物
の水溶液あるいは懸濁液に、有機酸、無機酸およびそれ
らの塩類を反応することにより水難溶性のカルシウム化
合物微粒子が合成される。沈殿法と称せられるように、
通常は生成した水難溶性無機微粒子は沈澱し、濾過後乾
燥あるいは熱分解することにより粉末を得る方法であ
る。As a method for synthesizing calcium compound fine particles, a liquid phase synthesis method is preferable. This is a so-called precipitation method, in which an organic acid, an inorganic acid and salts thereof are reacted with an aqueous solution or suspension of a water-soluble or hardly-soluble calcium compound to form a hardly water-soluble calcium compound fine particle. Synthesized. As called the precipitation method,
Usually, the produced water-insoluble inorganic fine particles are precipitated, filtered, and dried or thermally decomposed to obtain a powder.
【0013】本発明においては、前記したカルボキシル
基を含有する多糖類を沈殿法により製造された水難溶性
のカルシウム化合物懸濁液に混合し、機械的攪拌または
超音波照射などの物理的手法により、多糖類/カルシウ
ム化合物複合体および沈降・分離を抑えた分散溶液を製
造できる。しかしながら、この方法では沈殿法で製造す
る際にできやすい比較的大きな粒子や一次粒子の凝集体
を沈降なく均一に分散させることは困難を伴う場合があ
る。その場合には初期に沈降する成分を除去し、上層の
みを使えば良い。さらに分散安定性を向上させるには、
水難溶性のカルシウム化合物を合成する際にカルボキシ
ル基を含有する多糖類を存在させておくことによりカル
シウム化合物を合成する方法(in−situ法)を用
いる。この方法で生成する微粒子は沈澱することなく、
コロイド状に均一に分散した、極めて分散安定性に優れ
た多糖類/カルシウム化合物複合体分散溶液となるので
ある。なぜこのような分散安定性に優れた多糖類/カル
シウム化合物複合体分散溶液となるのか必ずしも完全に
解明された訳ではないが、以下の機構がもっとも確から
しいと推定している。In the present invention, the carboxyl group-containing polysaccharide is mixed with a poorly water-soluble calcium compound suspension produced by a precipitation method, and the suspension is subjected to a physical method such as mechanical stirring or ultrasonic irradiation. A polysaccharide / calcium compound complex and a dispersion solution with reduced sedimentation / separation can be produced. However, in this method, it may be difficult to uniformly disperse aggregates of relatively large particles or primary particles which are easily generated in the production by the precipitation method without sedimentation. In that case, it is only necessary to remove the components that settle at the beginning and use only the upper layer. To further improve dispersion stability,
When synthesizing a poorly water-soluble calcium compound, a method of synthesizing a calcium compound by using a polysaccharide containing a carboxyl group (in-situ method) is used. Fine particles generated by this method do not precipitate,
The resulting dispersion is a polysaccharide / calcium compound composite dispersion that is uniformly dispersed in a colloidal form and has extremely excellent dispersion stability. The reason why such a polysaccharide / calcium compound composite dispersion having excellent dispersion stability is obtained is not always completely elucidated, but it is presumed that the following mechanism is most likely.
【0014】本発明者らは、カルシウム化合物のカルシ
ウムイオンと多糖類のカルボキシル基の間にはイオン的
な結合が存在することを、pHやイオン強度に対する分
散安定性の実験事実から示している。このような相互作
用はin−situ法による反応過程においても存在す
るものと考えられ、反応により生成するカルシウム化合
物はその成長過程においてカルボキシル基を含有する多
糖類を吸着することは十分に考えられる。そのようにし
てカルシウム化合物に吸着した多糖類はカルシウム化合
物の結晶成長を阻害し、粒子径は500nm以上になら
ないものと考えられる。この場合、吸着した多糖類によ
り成長方向が影響を受けると粒子の形態が変化し、より
分散性が向上する可能性もある。たとえば、通常ヒドロ
キシアパタイトの一次粒子は針状となるが、多糖類存在
下に合成すると偏平な粒子となることが透過型電子顕微
鏡観察から確かめられた。このように粒子形状の変化に
より凝集が抑えられる効果も分散性が向上する要因の1
つであろう。また、このようにして生成した500nm
以下の水難溶性カルシウム化合物微粒子は、カルシウム
化合物に結合した多糖類が保護コロイド的な作用を示す
ために微粒子間の凝集は抑制され、その結果長期間凝集
を起こさず分散状態が安定に保たれるものと考えられ
る。すなわち多糖類の効果は、カルシウム化合物の
(1)結晶成長抑制、(2)粒子形態変化、(3)粒子
間凝集抑制、これらの何れかあるいはすべての作用によ
りもたらされ、単純混合に比べてin−situ法で製
造したもののほうがより分散性が優れることを合理的に
説明できる。The present inventors have shown that there is an ionic bond between a calcium ion of a calcium compound and a carboxyl group of a polysaccharide based on the experimental fact of dispersion stability against pH and ionic strength. It is considered that such an interaction exists also in the reaction process by the in-situ method, and it is sufficiently considered that the calcium compound generated by the reaction adsorbs a polysaccharide containing a carboxyl group in the growth process. It is considered that the polysaccharide thus adsorbed on the calcium compound inhibits the crystal growth of the calcium compound, and the particle diameter does not become 500 nm or more. In this case, if the growth direction is affected by the adsorbed polysaccharide, the morphology of the particles changes, and the dispersibility may be further improved. For example, it has been confirmed by transmission electron microscopy that the primary particles of hydroxyapatite are usually acicular, but become flat particles when synthesized in the presence of a polysaccharide. As described above, the effect of suppressing aggregation due to the change in particle shape is one of the factors that improve dispersibility.
One. Also, the 500 nm thus generated
In the following water-insoluble calcium compound fine particles, aggregation between the fine particles is suppressed because the polysaccharide bonded to the calcium compound exhibits a protective colloidal action, and as a result, the dispersion state is stably maintained without causing aggregation for a long time. It is considered something. In other words, the effect of the polysaccharide is brought about by (1) inhibition of crystal growth, (2) change in particle morphology, (3) inhibition of inter-particle aggregation, or any or all of these effects of the calcium compound. It can be rationally explained that those produced by the in-situ method have better dispersibility.
【0015】また、本発明のクエン酸塩/カルシウム化
合物複合体を含有するカルシウム補強剤の場合は、カル
シウム化合物を合成する際にクエン酸塩を存在させてお
くことによりカルシウム化合物を合成する方法(in−
situ法)を用いる。この方法で生成する化合物は沈
澱することなく、コロイド状に均一に分散した、極めて
分散安定性に優れたクエン酸塩/カルシウム化合物複合
体分散溶液となるのである。この方法においても多糖類
と同様の機構で説明でき、クエン酸塩は単に粒子の表面
を修飾するだけではなく、粒子製造の際に存在させてお
くと粒子形態を変化させる効果があるため、安定性が改
良された複合体分散溶液が製造できるものと考えられ
る。In the case of a calcium reinforcing agent containing the citrate / calcium compound complex of the present invention, a method of synthesizing a calcium compound by allowing a citrate to be present when synthesizing the calcium compound ( in-
(situ method). The compound formed by this method becomes a citrate / calcium compound composite dispersion having extremely excellent dispersion stability, which is uniformly dispersed in a colloidal form without precipitation. This method can be explained by the same mechanism as that of polysaccharides.Citrate not only modifies the surface of particles but also has the effect of changing the particle morphology if it is present during the production of particles, so that it is stable. It is considered that a composite dispersion having improved properties can be produced.
【0016】本発明のカルシウム化合物微粒子の合成に
使用されるカルシウム化合物の例としては、塩化カルシ
ウム、酢酸カルシウム、リン酸一水素カルシウム、リン
酸二水素カルシウム、乳酸カルシウム、クエン酸カルシ
ウム、グルコン酸カルシウム、水酸化カルシウム、炭酸
カルシウム、塩化カルシウム、硝酸カルシウム、硫酸カ
ルシウム、チオ硫酸カルシウムなどから選ばれる1種以
上の化合物があげられる。Examples of the calcium compound used for synthesizing the calcium compound fine particles of the present invention include calcium chloride, calcium acetate, calcium monohydrogen phosphate, calcium dihydrogen phosphate, calcium lactate, calcium citrate, and calcium gluconate. And at least one compound selected from calcium hydroxide, calcium carbonate, calcium chloride, calcium nitrate, calcium sulfate, calcium thiosulfate and the like.
【0017】本発明のカルシウム化合物微粒子の合成に
使用される無機酸、有機酸およびそれらの塩類は、上記
カルシウム化合物と反応して水に難溶なカルシウム化合
物微粒子を生成するものであればよい。なかでも炭酸、
リン酸(オルトリン酸)、ギ酸、酢酸、プロピオン酸、
酪酸、シュウ酸、マロン酸、コハク酸、グルタル酸、ア
ジピン酸、フマル酸、乳酸、リンゴ酸、酒石酸、塩化水
素酸などや、それらのアルカリ金属塩、アルカリ土類金
属塩が挙げられる。The inorganic acid, organic acid and salts thereof used in the synthesis of the calcium compound fine particles of the present invention may be any as long as they react with the above-mentioned calcium compound to form calcium compound fine particles which are hardly soluble in water. Above all, carbonic acid,
Phosphoric acid (orthophosphoric acid), formic acid, acetic acid, propionic acid,
Examples thereof include butyric acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, fumaric acid, lactic acid, malic acid, tartaric acid, and hydrochloric acid, and alkali metal salts and alkaline earth metal salts thereof.
【0018】カルシウム化合物微粒子がリン酸カルシウ
ムの場合について以下詳細に記述する。The case where the calcium compound fine particles are calcium phosphate will be described in detail below.
【0019】本発明においてリン酸カルシウムは、リン
酸に由来する部分とカルシウム原子の合計が50重量%
以上含まれるものである。例としてはヒドロキシアパタ
イト、フッ素アパタイト、塩素アパタイト、炭酸含有ア
パタイト、マグネシウム含有アパタイト、鉄含有アパタ
イト等のアパタイト化合物、リン酸三カルシウム等が挙
げられる。In the present invention, calcium phosphate has a total of 50% by weight of a portion derived from phosphoric acid and calcium atoms.
These are included. Examples include hydroxyapatite, fluoroapatite, chlorapatite, carbonate-containing apatite, magnesium-containing apatite, apatite compounds such as iron-containing apatite, and tricalcium phosphate.
【0020】本発明のリン酸カルシウムに含まれるアパ
タイト化合物は、基本組成がMx(RO4)yXzで表され
る。Mサイトがカルシウムイオン(Ca2+)、RO4サ
イトがリン酸イオン(PO4 3-)、Xサイトが水酸化イ
オン(OH-)の場合には、x=10、y=6、z=2
となり、一般的にヒドロキシアパタイトと呼ばれる化合
物である。M、RO4、Xの各サイトは、種々のイオン
等と置換が可能であり、また、空孔ともなり得るもので
ある。置換量および空孔量は、そのイオン等の種類によ
り異なるが、リン酸に由来する部分とカルシウム原子の
合計が50重量%以上含まれていれば、他のイオン等と
置換されていても、空孔であっても差し支えない。The basic composition of the apatite compound contained in the calcium phosphate of the present invention is represented by M x (RO 4 ) y X z . When the M site is a calcium ion (Ca 2+ ), the RO 4 site is a phosphate ion (PO 4 3− ), and the X site is a hydroxide ion (OH − ), x = 10, y = 6, z = 2
Which is a compound generally called hydroxyapatite. Each site of M, RO 4 , and X can be replaced with various ions and the like, and can also be vacancies. The amount of substitution and the amount of vacancies vary depending on the type of the ion or the like. A hole may be used.
【0021】リン酸に由来する部分とカルシウム原子の
合計が50重量%を下回るとリン酸カルシウムとしての
特性が失われることがあるために好ましくない。Mサイ
トは基本的にCa2+であるが、種々の金属イオンで置換
できることが知られている。食品用途で置換可能なイオ
ン種の例としては、H+、Na+、K+、H3O+、C
r2 +、Zn2+、Mg2+、Fe2+、Mn2+、Ni2+、Cu
2+、Fe3+、Co2+等があげられる。このように、Ca
2+に生体必須の微量元素を必要量だけ置換・導入するこ
とも可能である。RO4サイトは基本的にPO4 3-である
が、置換可能なイオン種の例として、SO4 2-、C
O3 2-、HPO4 2-、H4O4 4-等があげられる。Xサイト
に入るイオン種や分子の例として、OH-、Cl-、
I-、O2-、CO3 2-、H2O等があげられる。The portion derived from phosphoric acid and the calcium atom
If the total is less than 50% by weight, calcium phosphate
It is not preferable because properties may be lost. M rhino
Is basically Ca2+But replaced with various metal ions
It is known that it can be done. Io replaceable for food applications
For example, H+, Na+, K+, HThreeO+, C
rTwo +, Zn2+, Mg2+, Fe2+, Mn2+, Ni2+, Cu
2+, Fe3+, Co2+And the like. Thus, Ca
2+Replace and introduce the necessary amount of biologically essential trace elements
Both are possible. ROFourSite is basically POFour 3-Is
Is an example of a replaceable ionic species,Four 2-, C
OThree 2-, HPOFour 2-, HFourOFour Four-And the like. X site
Examples of ionic species and molecules that enter-, Cl-,
I-, O2-, COThree 2-, HTwoO and the like.
【0022】本発明のカルシウム補強剤中に含まれるリ
ン酸カルシウムの粒径は500nm以下である。粒径が
500nmを越えると粒子が沈降分離しやすくなり、分
散溶液の安定性に欠けるため適当ではない。また、リン
酸カルシウム結晶構造についてはいかなるものでもよ
く、非晶質でもよい。さらに、リン酸カルシウムの形状
についても特に制限はなく、球形、針状、柱状、不定形
等いかなる形状でもかまわない。粒径分布についても、
粒径が500nm以下であれば特に制限はない。ここで
用いる粒径とは、粒子の長軸径を示す。The particle size of calcium phosphate contained in the calcium reinforcing agent of the present invention is 500 nm or less. If the particle size exceeds 500 nm, the particles are liable to settle and separate, and the stability of the dispersion solution is poor. The calcium phosphate crystal structure may be any, and may be amorphous. Further, the shape of the calcium phosphate is not particularly limited, and may be any shape such as a sphere, a needle, a column, and an irregular shape. Regarding particle size distribution,
There is no particular limitation as long as the particle size is 500 nm or less. The particle size used here indicates the major axis diameter of the particle.
【0023】リン酸カルシウムはいかなる製造方法でも
かまわないが、所謂湿式法(液相法/沈殿法)が好まし
い。湿式法は、カルシウム化合物(懸濁)水溶液とリン
酸あるいはリン酸塩水溶液を混合することによりリン酸
カルシウムを合成する方法であり、一般的には両液を同
時滴下か、一方の溶液の中へ他方の溶液を滴下する方式
がとられる。滴下時間については特に制限はないが、概
ね5分〜24時間である。反応は滴下終了後、必要に応
じて熟成させる。The calcium phosphate may be produced by any method, but a so-called wet method (liquid phase method / precipitation method) is preferred. The wet method is a method of synthesizing calcium phosphate by mixing an aqueous solution of a calcium compound (suspension) and an aqueous solution of phosphoric acid or phosphate. Generally, both solutions are dropped simultaneously or the other solution is put into one solution. The method of dropping the solution is adopted. The dropping time is not particularly limited, but is generally about 5 minutes to 24 hours. After completion of the dropwise addition, the reaction is aged, if necessary.
【0024】分散安定性の優れたカルボキシル基を含有
する多糖類/リン酸カルシウム複合体分散溶液を製造す
る方法には前述した機械的に混合分散する方法とカルボ
キシル基を含有する多糖類存在下にリン酸カルシウムを
製造する方法(in−situ法)があるが、後者の方
法が好ましい。The method of preparing a carboxyl group-containing polysaccharide / calcium phosphate composite dispersion having excellent dispersion stability includes the above-mentioned mechanical mixing and dispersion method and the method of preparing calcium phosphate in the presence of a carboxyl group-containing polysaccharide. Although there is a manufacturing method (in-situ method), the latter method is preferable.
【0025】in−situ法において、カルボキシル
基を含有する多糖類はリン酸カルシウムが生成する反応
液中に存在させればよく、カルシウム化合物(懸濁)水
溶液、リン酸あるいはリン酸塩水溶液いずれかに混合し
ておいてもよいし、両方に混合しておいてもよい。ま
た、両者とは別に独立して反応器の中へ連続的あるいは
断続的に添加してもよい。In the in-situ method, the polysaccharide containing a carboxyl group may be present in a reaction solution in which calcium phosphate is formed, and is mixed with an aqueous solution of a calcium compound (suspension) or an aqueous solution of phosphoric acid or phosphate. Or both may be mixed. Moreover, you may add continuously and intermittently to a reactor independently from both.
【0026】本発明のリン酸カルシウムの合成に使用さ
れるカルシウム化合物の例としては、前記したカルシウ
ム化合物の合成に使用される化合物があげられる。Examples of the calcium compound used for synthesizing the calcium phosphate of the present invention include the compounds used for synthesizing the calcium compound described above.
【0027】本発明で使用されるリン酸あるいはリン酸
塩は、リン酸(オルトリン酸)、リン酸一水素カルシウ
ム、リン酸二水素カルシウム、リン酸二水素アンモニウ
ム、リン酸水素二アンモニウム、およびアンモニウム塩
以外のこれらのナトリウム、カリウム塩等があげられ
る。目的とする化合物以外の、反応に伴ない副生する有
機あるいは無機塩は、用途によっては除去する必要があ
り、その際は透析など既知の方法で脱塩する。リン酸カ
ルシウムを目的化合物とする場合には、水酸化カルシウ
ムとリン酸または炭酸カルシウムとリン酸一水素カルシ
ウムを原料にすれば副生塩は発生しないため特に好まし
い。また、リン酸カルシウムの中でもアパタイト構造を
とるものはその構造の柔軟さから前述のように各種イオ
ンと置換できることが知られており、必要に応じてカル
シウムおよびリン酸以外のイオン種を含む化合物を併用
することもできる。The phosphoric acid or phosphate used in the present invention includes phosphoric acid (orthophosphoric acid), calcium monohydrogen phosphate, calcium dihydrogen phosphate, ammonium dihydrogen phosphate, diammonium hydrogen phosphate, and ammonium These include sodium and potassium salts other than salts. Organic or inorganic salts other than the target compound, which are by-produced during the reaction, need to be removed depending on the use. In that case, desalting is performed by a known method such as dialysis. When calcium phosphate is used as the target compound, it is particularly preferable to use calcium hydroxide and phosphoric acid or calcium carbonate and calcium monohydrogen phosphate as raw materials since no by-product salt is generated. In addition, it is known that, among calcium phosphates, those having an apatite structure can be replaced with various ions as described above because of the flexibility of the structure, and a compound containing an ionic species other than calcium and phosphate is used in combination as necessary. You can also.
【0028】通常は反応溶液を所定温度に保つことによ
り反応を行う。反応中同一温度に保つ必要はなく、反応
の進行にともない適宜変えてよく、必要に応じて加熱あ
るいは冷却しながら行う。反応温度により生成するリン
酸カルシウム粒子の大きさが変化するため、反応温度を
変えることにより粒径を変えることができ、その結果分
散水溶液から作成されるフイルムの透明性を加減するこ
とも可能である。反応温度は概ね5〜95℃の範囲にあ
る。反応器内の雰囲気は特に限定はなく通常は空気中で
行われるが、リン酸カルシウムの組成をコントロールす
るには窒素ガスのような不活性ガスで置換した方がよ
い。合成時間は特に限定はないが、滴下、熟成時間を合
わせて概ね1〜120時間である。Usually, the reaction is carried out by keeping the reaction solution at a predetermined temperature. It is not necessary to maintain the same temperature during the reaction, and the temperature may be appropriately changed as the reaction proceeds. The reaction is performed while heating or cooling as necessary. Since the size of the calcium phosphate particles generated by the reaction temperature changes, the particle size can be changed by changing the reaction temperature, and as a result, the transparency of the film prepared from the aqueous dispersion solution can be adjusted. The reaction temperature is generally in the range of 5-95C. The atmosphere in the reactor is not particularly limited and is usually carried out in air. However, in order to control the composition of calcium phosphate, it is better to substitute an inert gas such as nitrogen gas. The synthesis time is not particularly limited, but is generally about 1 to 120 hours in total for the time of dropping and aging.
【0029】攪拌方法については、均一に混合される方
法であれば特に制限はなく、例として回転による方法、
超音波による方法等があげられる。攪拌羽根を用いたバ
ッチ式の反応容器を用いる場合、攪拌羽根の形状や溶液
粘度等に影響されるため一概にはいえないが、攪拌速度
は概ね30〜10000rpmの範囲である。The stirring method is not particularly limited as long as it is a method of uniformly mixing.
Examples include a method using ultrasonic waves. When a batch-type reaction vessel using a stirring blade is used, it cannot be said unconditionally because it is affected by the shape of the stirring blade, the solution viscosity, and the like, but the stirring speed is generally in the range of 30 to 10,000 rpm.
【0030】反応溶媒としては水を用いるが、エタノー
ル、グリセリン等の食品用途で使用される有機溶剤を併
用してもよい。Water is used as the reaction solvent, but organic solvents such as ethanol and glycerin used in food applications may be used in combination.
【0031】合成する際の濃度は特に制限はないが、リ
ン酸カルシウムとカルボキシル基を含有する多糖類の固
形分を合わせて概ね0.5〜60重量%の範囲であり、
好ましくは1〜50重量%の範囲にある。50重量%を
越えると分散液の粘度が高くなり、取り扱いが困難とな
る場合がある。The concentration at the time of synthesis is not particularly limited, but is generally in the range of 0.5 to 60% by weight in total with the solid content of calcium phosphate and polysaccharide containing a carboxyl group.
Preferably it is in the range of 1 to 50% by weight. If it exceeds 50% by weight, the viscosity of the dispersion may increase, and handling may be difficult.
【0032】リン酸カルシウムは、反応時のpHにより
生成するリン酸カルシウムの種類が異なるため、特定の
種を製造する場合にはpHを調整しながら行うこともあ
る。pH調整は水酸化ナトリウム、水酸化カリウム等に
より行うことができる。特に、目的化合物がpH変化
により溶解する場合、カルボキシル基の解離状態変化
により複合体が分離するような場合には厳密にpH調整
を行う必要がある。例えば、ヒドロキシアパタイト(リ
ン酸カルシウム)の場合には、反応後はの理由からp
H5以下にならないように適宜アルカリを添加して調整
する。Since the type of calcium phosphate produced differs depending on the pH at the time of the reaction, the production of a specific species may be performed while adjusting the pH. The pH can be adjusted with sodium hydroxide, potassium hydroxide or the like. In particular, when the target compound dissolves due to a change in pH, or when the complex is separated due to a change in the dissociation state of the carboxyl group, it is necessary to strictly adjust the pH. For example, in the case of hydroxyapatite (calcium phosphate), p
It is adjusted by adding an alkali appropriately so as not to become H5 or less.
【0033】かくして得られる安定性に優れるカルボキ
シル基を含有する多糖類/リン酸カルシウム複合体分散
溶液は、均一なエマルション溶液であり、長時間静置し
ておいても沈降、分離を起こさない。ここで言う安定性
に優れるものとは、カルシウム化合物濃度が0.5%のと
きに沈降あるいは分離する容積が1週間経過した時点で
3vol%以下のものを言う。The carboxyl group-containing polysaccharide / calcium phosphate composite dispersion thus obtained, which is excellent in stability, is a uniform emulsion solution and does not cause sedimentation or separation even when left for a long time. The term "excellent in stability" as used herein means that the volume of sedimentation or separation at a calcium compound concentration of 0.5% is 3 vol% or less after one week.
【0034】水に難溶なカルシウム化合物微粒子が炭酸
カルシウムの場合にもリン酸カルシウムと同様の方法で
製造される。この場合には、カルシウム源としては、リ
ン酸カルシウムと同一の原料が使用でき、炭酸源には、
炭酸ガス、炭酸ナトリウム、炭酸水素ナトリウム、炭酸
カリウム、炭酸水素カリウム、炭酸アンモニウムなどが
適宜使用される。リン酸カルシウムの場合と同様に、副
生塩を発生させないためには、水酸化カルシウムと炭酸
(ガス)の組み合わせが好ましい。When the calcium compound fine particles which are hardly soluble in water are calcium carbonate, they are produced in the same manner as calcium phosphate. In this case, the same raw material as calcium phosphate can be used as the calcium source, and
Carbon dioxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, ammonium carbonate and the like are appropriately used. As in the case of calcium phosphate, a combination of calcium hydroxide and carbonic acid (gas) is preferable in order not to generate by-product salts.
【0035】本発明のカルシウム補強剤は上記の手法に
より、水に難溶なカルシウム化合物を水系の分散媒に分
散したエマルションの形態で製造される。このエマルシ
ョンはそのままの状態で食品に添加できるが、使用され
る用途に応じて予めショ糖脂肪酸エステルやソルビタン
脂肪酸エステル、レシチンなどの乳化剤、アスコルビン
酸やトコフェノール等の酸化防止剤、各種(多)糖類、
各種アミノ酸類、コラーゲンやゼラチン、カゼイン、ア
ルブミン等のタンパク質、各種ビタミン類、グルコン酸
やリンゴ酸、クエン酸などの食用酸、グリセリンなどの
多価アルコール、ソルビン酸カリウム等の防腐剤、保存
料などを添加しておいてもよい。The calcium reinforcing agent of the present invention is produced in the form of an emulsion in which a water-insoluble calcium compound is dispersed in an aqueous dispersion medium by the above-mentioned method. This emulsion can be added to food as it is, but depending on the intended use, emulsifiers such as sucrose fatty acid ester, sorbitan fatty acid ester, lecithin, antioxidants such as ascorbic acid and tocophenol, various (multi) Sugars,
Various amino acids, proteins such as collagen, gelatin, casein and albumin, various vitamins, food acids such as gluconic acid, malic acid, and citric acid, polyhydric alcohols such as glycerin, preservatives such as potassium sorbate, preservatives, etc. May be added.
【0036】本発明のカルシウム補強剤は、このように
して得られる分散安定性に優れるカルボキシル基を含有
する多糖類/カルシウム化合物複合体またはクエン酸塩
/カルシウム化合物複合体から水を除去することにより
固形化することも可能である。複合体は用途に応じて、
公知の方法や機器を用いてフィルム状、シート状、粉末
状、発泡体状、糸状など任意の形状に加工することがで
きる。The calcium reinforcing agent of the present invention is obtained by removing water from the carboxyl group-containing polysaccharide / calcium compound complex or citrate / calcium compound complex having excellent dispersion stability thus obtained. It is also possible to solidify. Depending on the application, the composite
It can be processed into an arbitrary shape such as a film, a sheet, a powder, a foam, and a thread by using a known method or equipment.
【0037】また、温度変化により物理的に架橋構造を
つくる方法や、架橋剤を用いて化学的な結合(イオン結
合、共有結合)で架橋構造をつくる方法により、ゲル状
に加工することも可能である。It is also possible to process into a gel by a method of physically forming a crosslinked structure by a temperature change or a method of forming a crosslinked structure by a chemical bond (ionic bond or covalent bond) using a crosslinking agent. It is.
【0038】例えば、フィルムに加工する場合には、分
散水溶液をそのまま、あるいは濃縮処理やpH調整、必
要に応じてグリセリン等の可塑剤や、架橋剤、増粘剤、
着色剤、酸化防止剤等の添加剤を混合した後に、ガラ
ス、石英、金属、セラミックス、プラスチック、ゴム等
の基板、ロール、ベルト等の上に上記の安定な分散液を
塗布・製膜し、必要に応じて加熱、減圧、送気、赤外線
照射、極超短波照射等の処理を行って水および/または
水系の溶剤を蒸発させることにより製造することができ
る。塗布方法は特に制限はなく、流し塗り法、浸漬法、
スプレー法等があり、バーコーター、スピンコーター、
ナイフコーター、ブレードコーター、カーテンコータ
ー、グラビアコーター、スプレーコーター等の公知の塗
工機を使用できる。塗布厚み(乾燥前の厚み)は概ね1
μm〜10mmで、塗布法の選択により任意に厚みを設
定できる。水および/または水系の溶剤を蒸発させる温
度は0〜150℃の温度範囲で行い、常圧あるいは減圧
下に行う。その際に乾燥空気あるいは乾燥窒素を流通さ
せて乾燥時間を短縮することができる。さらに、耐水性
を付与する等の目的で架橋反応を促進する場合には、4
0〜200℃で数秒〜数十分間熱処理を行う。このフィ
ルムを基材から剥がして使用する場合には、プラスチッ
ク製の基材を用いると離型性が良好であるが、その他の
基材を用いる場合にも必要に応じて各素材に公知の離型
剤を予め塗布するとよい。このようにして製造されるフ
ィルムは透明性に優れる特徴を有する。これは、リン酸
カルシウム微粒子のサイズが可視光の波長領域以下であ
り、個々の粒子が凝集を起こすことなくポリマーマトリ
ックス中に均一に分散していることを示す。For example, in the case of processing into a film, the aqueous dispersion solution is used as it is, or a concentration treatment, pH adjustment, a plasticizer such as glycerin, a crosslinking agent, a thickener,
After mixing additives such as coloring agents and antioxidants, the above stable dispersion is applied and formed on a substrate such as glass, quartz, metal, ceramics, plastic, and rubber, a roll, a belt, and the like, If necessary, it can be produced by performing a treatment such as heating, decompression, air supply, infrared irradiation, or ultrashort wave irradiation to evaporate water and / or an aqueous solvent. There is no particular limitation on the application method, a flow coating method, a dipping method,
There are spray method, bar coater, spin coater,
Known coating machines such as a knife coater, a blade coater, a curtain coater, a gravure coater, and a spray coater can be used. The coating thickness (thickness before drying) is approximately 1
The thickness can be arbitrarily set in the range of μm to 10 mm by selecting a coating method. The temperature for evaporating water and / or the aqueous solvent is in a temperature range of 0 to 150 ° C., and the pressure is reduced to normal pressure or reduced pressure. At that time, the drying time can be shortened by flowing dry air or dry nitrogen. Further, when a crosslinking reaction is promoted for the purpose of imparting water resistance, for example, 4
The heat treatment is performed at 0 to 200 ° C. for several seconds to several tens minutes. When the film is peeled off from the base material, the use of a plastic base material provides good releasability, but when other base materials are used, a known release property may be applied to each material as necessary. It is preferable to apply a mold agent in advance. The film produced in this way has a feature of excellent transparency. This indicates that the size of the calcium phosphate fine particles is not more than the wavelength region of visible light, and that the individual particles are uniformly dispersed in the polymer matrix without causing aggregation.
【0039】カルボキシル基を含有する多糖類/カルシ
ウム化合物複合体分散溶液から複合体を粉末化する方法
は、フィルム加工と同様に複合体の分散水溶液をそのま
ま、あるいは濃縮処理やpH調整、必要に応じてグリセ
リン等の可塑剤や、架橋剤、増粘剤、着色剤、酸化防止
剤等の添加剤を混合した後に、スプレードライ、凍結乾
燥のように溶媒を分散液から直接気化する方法や、ある
いは水と混和するが複合体を溶解しないメタノールのよ
うな有機溶剤または硫酸ナトリウムのような塩析効果の
高い化合物を用いることにより固体分離処理を行い、乾
燥後粉末化する方法も可能である。The method of pulverizing the complex from the carboxyl group-containing polysaccharide / calcium compound complex dispersion solution can be carried out in the same manner as in the film processing, by using the aqueous dispersion of the complex as it is, or by performing a concentration treatment, pH adjustment, and if necessary. After mixing additives such as a plasticizer such as glycerin, a crosslinking agent, a thickener, a coloring agent, and an antioxidant, a method of directly vaporizing a solvent from a dispersion liquid such as spray drying or freeze drying, or A method of performing a solid separation treatment by using an organic solvent such as methanol which is miscible with water but not dissolving the complex or a compound having a high salting-out effect such as sodium sulfate, drying and pulverizing is also possible.
【0040】その他の形状加工についても、フィルム加
工と同様に、複合体の分散溶液をそのまま、あるいは濃
縮処理やpH調整、必要に応じてグリセリン等の可塑剤
や、架橋剤、増粘剤、着色剤、酸化防止剤、熱安定剤等
の添加剤を混合した後に、公知の方法により実施でき
る。As for other shape processing, as in the case of film processing, the dispersion solution of the complex is used as it is, or is subjected to concentration treatment, pH adjustment, and if necessary, a plasticizer such as glycerin, a crosslinking agent, a thickener, a coloring agent. After mixing additives such as an agent, an antioxidant and a heat stabilizer, it can be carried out by a known method.
【0041】本発明のカルシウム補強剤は無味無臭であ
り、添加される食品の食味に全く影響を及ぼさないた
め、種々の食品に添加できる。なかでも水に対する分散
性に優れている点で液状の食品に添加される場合に最も
利用価値が高いが、フイルムや粉末などにも加工可能で
ある点を利用して、固形の食品に添加することも可能で
ある。Since the calcium reinforcing agent of the present invention is tasteless and odorless and has no effect on the taste of the food to be added, it can be added to various foods. Among them, it is most useful when added to liquid foods because of its excellent dispersibility in water, but it is added to solid foods because it can be processed into films and powders. It is also possible.
【0042】本発明のカルシウム補強剤が使用される液
状の食品の例としては、牛乳、加工乳、乳飲料、発酵
乳、乳酸菌飲料、果汁、野菜搾汁、コーヒー、紅茶、緑
茶、麦茶、ウーロン茶、野草茶、ココア、豆乳、しる
こ、清涼飲料、内服液、味噌汁、スープ、ドレッシン
グ、液体調味料などがあり、これらの例に限定されるも
のではなく広範囲に使用可能である。Examples of the liquid food in which the calcium reinforcing agent of the present invention is used include milk, processed milk, milk drink, fermented milk, lactic acid drink, fruit juice, vegetable juice, coffee, black tea, green tea, barley tea, and oolong tea. , Wild grass tea, cocoa, soy milk, shiruko, soft drink, oral liquid, miso soup, soup, dressing, liquid seasoning, etc., and are not limited to these examples, but can be used in a wide range.
【0043】本発明のカルシウム補強剤が使用される固
形の食品の例としては、チーズ、プリン、ゼリー、パ
ン、麺類、ハムやソーセージ等の加工肉類、漬物や乾燥
野菜等の加工野菜類、加工魚類、米飯類、餡子類、羊
羹、クリーム類、チョコレートやガム、キャラメル、ク
ッキー、せんべい、キャンディー、ポップコーン、ポテ
トチップス等の菓子類、粉ミルク、固体調味料などがあ
り、これらの例に限定されるものではなく一般の食品に
広範囲に使用可能である。Examples of solid foods to which the calcium supplement of the present invention is used include processed meats such as cheese, pudding, jelly, bread, noodles, ham and sausage, processed vegetables such as pickles and dried vegetables, and processed foods. There are fish, cooked rice, bean paste, yokan, creams, chocolate and gum, caramel, cookies, rice crackers, candy, popcorn, potato chips and other confectionery, powdered milk, solid seasonings, etc., and are limited to these examples. It can be widely used for general foods.
【0044】さらには、錠剤、顆粒剤、液剤などの医薬
品用途や、飼料添加物、配合飼料、ペットフードなどの
飼料にも使用可能である。Further, it can be used for pharmaceutical applications such as tablets, granules and liquids, and also for feeds such as feed additives, compound feeds and pet foods.
【0045】本発明のカルシウム補強剤は、食品に添加
されても食品の持つ本来の食感や食味に影響を及ぼすこ
となく摂取可能であり、また液状の飲食料に添加しても
長期にわたり沈降することなく安定に分散するため、食
品の風味などを損ねることがない。The calcium supplement of the present invention can be ingested without affecting the original texture and taste of food even when added to food, and can be precipitated for a long time even when added to liquid food or drink. It does not disturb the flavor and the like of the food because it is dispersed stably.
【0046】[0046]
【実施例】以下、実施例で本発明を詳細に説明するが、
本発明はこれらの実施例に限定されるものではない。ま
た、以下の例において用いる%は特記のない限り重量基
準を示す。X線回折による分析は、RINT X-ray D
iffractometer (理学電機社製)を用いて行った。FT
−IR測定は、日本分光社製のFT/IR−8300フ
ーリエ変換赤外分光光度計を用いて行った。透過型電子
顕微鏡(TEM)観察は、H−300型日立電子顕微鏡
(日立製作所社製)を用いて行った。Hereinafter, the present invention will be described in detail with reference to Examples.
The present invention is not limited to these examples. Further,% used in the following examples is based on weight unless otherwise specified. Analysis by X-ray diffraction is RINT X-ray D
The measurement was performed using an iffractometer (manufactured by Rigaku Denki Co., Ltd.). FT
-IR measurement was performed using FT / IR-8300 Fourier transform infrared spectrophotometer manufactured by JASCO Corporation. Transmission electron microscope (TEM) observation was performed using an H-300 type Hitachi electron microscope (manufactured by Hitachi, Ltd.).
【0047】[製造例1]攪拌機、温度計、pHメータ
ーを備えた丸底セパラブルフラスコに水酸化カルシウム
(関東化学社製、高純度試薬、3N)18.44g、蒸留水58
1.56gを入れ、激しく攪拌して懸濁液とした。懸濁液の
温度を40℃に調整した後、75%リン酸(三井化学社製)
を10.6%に希釈した水溶液153.66g、蒸留水246.34gを混
合溶解した水溶液を、ミクロチューブポンプを用いて連
続的に2時間かけて添加した。添加後さらに40℃で2時
間反応を行ない、リン酸カルシウム微粒子分散溶液を得
た。この反応は同一の条件で2度行った。これらの反応
液は1夜放置でそれぞれ50vol%が沈降した。上澄液
を捨てて両液を混合し、さらに2日放置して分離した上
澄液を取り除き、未処理のリン酸カルシウム分散スラリ
ーを調整した。このスラリーの固形分濃度は6.24%であ
り、長期保存するとさらに分離が認められたが、以下の
試験では使用前に良く混合分散してから使った。Production Example 1 18.44 g of calcium hydroxide (Kanto Chemical Co., high-purity reagent, 3N) and distilled water 58 were placed in a round-bottom separable flask equipped with a stirrer, thermometer, and pH meter.
1.56 g was added and stirred vigorously to form a suspension. After adjusting the temperature of the suspension to 40 ° C., 75% phosphoric acid (manufactured by Mitsui Chemicals, Inc.)
An aqueous solution obtained by mixing and dissolving 153.66 g of an aqueous solution diluted with 10.6% and 246.34 g of distilled water was continuously added over 2 hours using a microtube pump. After the addition, the reaction was further performed at 40 ° C. for 2 hours to obtain a calcium phosphate fine particle dispersion. This reaction was performed twice under the same conditions. When these reaction solutions were left overnight, 50 vol% of each of them settled out. The supernatant was discarded, the two solutions were mixed, and the mixture was allowed to stand for 2 days to remove the separated supernatant, thereby preparing an untreated calcium phosphate dispersion slurry. The solid content of this slurry was 6.24%, and further separation was observed after long-term storage. However, in the following tests, the slurry was mixed and dispersed well before use.
【0048】〔複合化実施例1〕攪拌機、温度計を備え
た丸底セパラブルフラスコにクエン酸一水和物(純正化
学社製、特級)5.089g に蒸留水133.40gを入れ均一に攪
拌溶解した後、40%水酸化ナトリウム水溶液6.90g、さ
らに10%水酸化ナトリウム水溶液1.84gを添加してpH
を8.30に調整した。水酸化カルシウム(関東化学製、高
純度試薬、3N)4.61gを攪拌しながら加えて懸濁液と
した。懸濁液の温度を40℃に調整し、攪拌速度300rpmで
攪拌しながら、10.5%リン酸水溶液34.57g 、蒸留水65.
43gを混合した水溶液をミクロチューブポンプで連続的
に2時間かけて添加した。添加後さらに40℃で2時間反
応を行ない、クエン酸ナトリウム/リン酸カルシウム複
合体(50:50)分散溶液(a−1)を得た。得られ
た分散溶液のpHは12.22であり、沈降物の生成はほと
んど認められなかった。複合化比較例1に比べると沈降
物の生成量は大幅に低減した。さらに数週間静置しても
分離、沈降等の変化を起こさずに安定であった。この分
散溶液の固形分濃度は5.50 %であった。[Compounding Example 1] In a round-bottom separable flask equipped with a stirrer and a thermometer, 5.089 g of citric acid monohydrate (manufactured by Junsei Chemical Co., Ltd., special grade) was added, and 133.40 g of distilled water was uniformly stirred and dissolved. After adding 6.90 g of a 40% aqueous sodium hydroxide solution and 1.84 g of a 10% aqueous sodium hydroxide solution, pH was added.
Was adjusted to 8.30. 4.61 g of calcium hydroxide (manufactured by Kanto Chemical Co., high purity reagent, 3N) was added with stirring to form a suspension. The temperature of the suspension was adjusted to 40 ° C, and while stirring at a stirring speed of 300 rpm, 34.57 g of a 10.5% phosphoric acid aqueous solution and 65.
The aqueous solution mixed with 43 g was continuously added by a micro tube pump over 2 hours. After the addition, the mixture was further reacted at 40 ° C. for 2 hours to obtain a sodium citrate / calcium phosphate composite (50:50) dispersion solution (a-1). The pH of the resulting dispersion was 12.22, and almost no sediment was formed. The amount of sediment produced was greatly reduced as compared with the composite comparative example 1. It was stable without any change such as separation or sedimentation even after standing for several weeks. The solid content of this dispersion was 5.50%.
【0049】〔複合化実施例2〕製造例1で得られたリ
ン酸カルシウム分散スラリー20.03g、カルボキシメチル
セルロース(CMC:セロゲンF−5A;(株)第一工
業製薬社製)水溶液(9.98%)12.53g、蒸留水17.55gを
混合溶解後、室温にて90分間超音波照射処理を行った。
処理直後は良好な分散溶液(b−1)を与えたが、比較
的短期間で沈降する成分があり、1週間室温で放置する
と液量に対して2.5vol%程度の沈降物が認められた。し
かしながら、CMCを添加しないリン酸カルシウムスラ
リーは完全に分離・沈降して透明な上澄液を生じたが、
CMCで処理した分散液は全体的に白濁したエマルショ
ンであり、初期に生成する沈降物を除去するとそれ以上
の沈澱物の生成は認められず、安定な分散液として存在
した。なお、この沈降物は軽く攪拌するだけで容易に再
分散した。[Composite Example 2] 20.03 g of the calcium phosphate dispersion slurry obtained in Production Example 1, 12.53 g of an aqueous solution (9.98%) of carboxymethylcellulose (CMC: cellogen F-5A; manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) After mixing and dissolving 17.55 g of distilled water, ultrasonic irradiation was performed at room temperature for 90 minutes.
Immediately after the treatment, a good dispersion solution (b-1) was given, but there was a component that settled in a relatively short period of time, and when left at room temperature for one week, a sediment of about 2.5 vol% with respect to the liquid amount was recognized. . However, the calcium phosphate slurry without the addition of CMC completely separated and settled to produce a clear supernatant,
The dispersion treated with CMC was an entirely cloudy emulsion, and when the precipitate formed at the initial stage was removed, no further precipitate was formed and the dispersion was present as a stable dispersion. The sediment was easily redispersed only by light stirring.
【0050】〔複合化実施例3〕攪拌機、温度計を備え
た丸底セパラブルフラスコに予め蒸留水で溶解しておい
たカルボキシメチルセルロース(CMC:セロゲンF−
5A;(株)第一工業製薬社製)水溶液(4.90%)102.
04g 、蒸留水14.27gを入れ均一に混合した後、水酸化カ
ルシウム(入交産業製)3.688gを攪拌しながら加えて懸
濁液とした。懸濁液の温度を40℃に調整し、攪拌速度30
0rpmで攪拌しながら、10.5%リン酸水溶液27.82g 、蒸
留水52.18gを混合した水溶液をミクロチューブポンプで
連続的に2時間かけて添加した。添加後さらに40℃で2
時間反応を行ない、カルボキシメチルセルロース/リン
酸カルシウム複合体(50:50)分散溶液(c−1)
を得た。得られた分散溶液のpHは11.60であり、沈降
物の生成はほとんど認められなかった。複合化実施例2
に比較すると沈降物の生成量は大幅に減少した。さらに
数週間静置しても分離、沈降等の変化を起こさずに安定
であった。この複合体分散液をIR用の窓板(KRS−
5)に直接キャストしたフイルムのIRスペクトルを図
1に示す。分散溶液を凍結乾燥により粉末化した試料の
XRDスペクトルを図2に示す。図1、図2の結果よ
り、この分散溶液はCMCとヒドロキシアパタイトから
構成されていることが示される。また、この分散溶液を
希釈し、コロジオン膜張銅メッシュ上で乾燥して撮影し
た透過型電子顕微鏡写真を図3に示す。この図は粒径が
100nm程度のヒドロキシアパタイト粒子が凝集する
ことなく分散していることを示す。さらに、食品添加用
の試験に用いるため反応液を100.03gとり、室温攪拌下1
0.5%リン酸水溶液を滴下してpHを7.02に調整した。
所要リン酸量は1.336gであり、この時点でのCa/Pの
比率は1.52であった。pH調整後の分散水溶液(c−
2)の固形分濃度は5.0 %であった。[Compounding Example 3] Carboxymethylcellulose (CMC: Cellogen F-) previously dissolved in distilled water in a round bottom separable flask equipped with a stirrer and a thermometer was used.
5A; Daiichi Kogyo Seiyaku Co., Ltd.) aqueous solution (4.90%) 102.
After adding 04g and 14.27g of distilled water and mixing uniformly, 3.688g of calcium hydroxide (manufactured by Iriko Sangyo) was added with stirring to form a suspension. The temperature of the suspension was adjusted to 40 ° C and the stirring speed was 30
While stirring at 0 rpm, an aqueous solution obtained by mixing 27.82 g of a 10.5% phosphoric acid aqueous solution and 52.18 g of distilled water was continuously added over 2 hours by a microtube pump. After addition, at 40 ° C 2
Reaction was performed for a time, and a carboxymethylcellulose / calcium phosphate composite (50:50) dispersion solution (c-1) was obtained.
I got The pH of the resulting dispersion was 11.60, and almost no sediment was formed. Example 2 of compounding
The amount of sediment produced was significantly reduced as compared to. It was stable without any change such as separation or sedimentation even after standing for several weeks. This composite dispersion is applied to an IR window plate (KRS-
FIG. 1 shows the IR spectrum of the film directly cast in 5). FIG. 2 shows an XRD spectrum of a sample obtained by powdering the dispersion solution by freeze-drying. The results of FIGS. 1 and 2 show that this dispersion solution is composed of CMC and hydroxyapatite. FIG. 3 shows a transmission electron micrograph taken by diluting this dispersion solution and drying it on a collodion film-coated copper mesh. This figure shows that hydroxyapatite particles having a particle size of about 100 nm are dispersed without aggregation. Further, 100.03 g of the reaction solution was taken for use in a test for food addition, and stirred at room temperature for 1 hour.
0.5% phosphoric acid aqueous solution was added dropwise to adjust the pH to 7.02.
The required amount of phosphoric acid was 1.336 g, and the Ca / P ratio at this time was 1.52. Dispersed aqueous solution (c-
The solid concentration of 2) was 5.0%.
【0051】〔複合化比較例1〕製造例1で得られたリ
ン酸カルシウム分散スラリー20.0g、クエン酸三ナトリ
ウム二水和物(和光純薬社製、特級)1.42g、蒸留水28.
55gを混合溶解後、室温にて90分間超音波照射処理を行
った。処理直後でも一部沈降物が認められ、1週間室温
で放置すると液量に対して約10vol%の沈降物が認めら
れた。さらに室温で1ヶ月放置すると、透明な上澄液が
分離した。[Comparative Comparative Example 1] 20.0 g of the calcium phosphate dispersion slurry obtained in Production Example 1, 1.42 g of trisodium citrate dihydrate (special grade, manufactured by Wako Pure Chemical Industries, Ltd.), 28.
After mixing and dissolving 55 g, ultrasonic irradiation was performed at room temperature for 90 minutes. Immediately after the treatment, some sediment was observed, and when left at room temperature for one week, about 10 vol% of sediment based on the liquid amount was observed. When left at room temperature for another month, a clear supernatant liquid was separated.
【0052】〔牛乳への添加試験〕市販牛乳(明治北海
道牛乳ブリックLL、常温保存可能品)100.0g当たり添
加剤と蒸留水を合せて10.0g混合し、5時間室温で放置
後5℃の冷蔵庫中で保管し、経時変化を観察した。添加
剤に含まれるヒドロキシアパタイト量は250mg(Caと
して100mg)になるように設定した。 (1)ブランク試験:蒸留水10.0gのみ添加して変化を
追った。5時間後のpHは6.74であった。ほとんど変化
は認められず、10日後に液をひっくり返すと白い薄膜
が残る程度であった。 (2)未処理品:製造例1で得られたリン酸カルシウム
分散スラリー4.02gと蒸留水5.98gを添加して変化を追っ
た。5時間後のpHは6.67であった。5時間後で3.6vol
%程度の薄い沈澱物が認められ、その後次第に濃い白色
沈澱に変化し、10日後には4.8vol%程度の沈澱物が認
められた。 (3)CMC処理品:複合化実施例3で得られた分散溶
液(c−2)10.0gを添加して変化を追った。5時間後
のpHは6.70であった。ほとんど変化は認められず、1
日後に液をひっくり返すと白い薄膜が観察される程度で
あり、10日後でもその薄膜がごく僅かに濃くなった
が、ブランク試験との明瞭な差は区別できなかった。[Addition test to milk] A total of 100.0 g of commercial milk (Meiji Hokkaido Milk Brick LL, storable at room temperature) was mixed with 10.0 g of the additive and distilled water, left at room temperature for 5 hours, and then cooled at 5 ° C. , And observed over time. The amount of hydroxyapatite contained in the additive was set to 250 mg (100 mg as Ca). (1) Blank test: Change was pursued by adding only 10.0 g of distilled water. The pH after 5 hours was 6.74. Little change was observed, and the solution was turned upside down after 10 days, leaving only a white thin film. (2) Untreated product: 4.02 g of the calcium phosphate dispersion slurry obtained in Production Example 1 and 5.98 g of distilled water were added to follow the change. After 5 hours, the pH was 6.67. 3.6vol 5 hours later
%, And then gradually changed to a dark white precipitate. After 10 days, about 4.8 vol% of the precipitate was observed. (3) CMC-treated product: Compounding 10.0 g of the dispersion solution (c-2) obtained in Example 3 was added to follow the change. After 5 hours, the pH was 6.70. Little change observed, 1
When the solution was turned over after one day, a white thin film was observed. Even after 10 days, the thin film became very dark, but a clear difference from the blank test could not be distinguished.
【0053】〔炊飯試験〕精米(あきたこまち)2合を
泡立て器とザルを用いて数回繰り返しよく洗い、最後に
ザルで十分に水を切った後に水道水400mlを入れ、複
合化実施例3で得られた分散液(c−2)20.0gを添加
・混合し、家庭用炊飯器を用いてかためモードで炊飯し
た。これは精米1合当たりCa換算で100mg添加される
条件である。米飯は艶があり、食感、食味についても無
添加系に比べて差異が認められなかった。[Rice Cooking Test] Two sets of milled rice (Akitakomachi) were washed well several times using a whisk and a colander, and after thoroughly draining the colander, 400 ml of tap water was added. 20.0 g of the obtained dispersion liquid (c-2) was added and mixed, and rice was cooked in a home rice cooker mode. This is a condition under which 100 mg of Ca is added per milled rice. The cooked rice was glossy, and no difference was observed in texture and taste as compared with the non-added type.
【0054】[0054]
【発明の効果】本発明のカルシウム補強剤は水中で極め
て安定であり、しかも食感や食味にほとんど影響を及ぼ
さないことから、従来は使用が困難であった液状食品に
分離や沈降等の問題を起こすことなく好適に使用でき
る。また本発明のカルシウム補強剤は固形の食品にも問
題なく使用できるし、フイルムや粉末などにも加工でき
ることから、従来とは違った形態での使用が可能であ
り、用途範囲が大きく広がる。The calcium supplement of the present invention is extremely stable in water and hardly affects the texture and taste. Can be suitably used without causing the Further, since the calcium reinforcing agent of the present invention can be used for solid foods without any problem and can be processed into films, powders, and the like, it can be used in a form different from conventional ones, and the range of applications is greatly expanded.
【図1】本発明に係わる複合体分散溶液(c−1)のI
Rスペクトル図である。FIG. 1 shows I of a composite dispersion solution (c-1) according to the present invention.
It is an R spectrum figure.
【図2】本発明に係わる複合体分散溶液(c−1)を凍
結乾燥により粉末化した試料のXRDスペクトル図であ
る。FIG. 2 is an XRD spectrum of a sample obtained by freeze-drying the complex dispersion solution (c-1) according to the present invention.
【図3】本発明に係わる複合分散溶液(c−1)を希釈
しコロジオン膜張銅メッシュ上で乾燥して撮影した透過
型電子顕微鏡写真である。FIG. 3 is a transmission electron micrograph taken by diluting the composite dispersion solution (c-1) according to the present invention and drying the diluted solution on a copper mesh covered with a collodion membrane.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 47/12 A61K 47/12 47/36 47/36 A61P 3/02 A61P 3/02 // B01F 17/38 B01F 17/38 17/56 17/56 Fターム(参考) 4B018 MD04 MD33 MD35 ME14 MF10 4C076 AA22 BB01 CC40 DD43F EE30F FF16 FF43 4C086 AA01 HA04 HA16 HA19 MA02 MA05 MA23 MA52 NA03 ZC21 4D077 AA02 AB08 AC05 BA07 CA02 CA12 DA02Y DC12Y DC26Y DC28Y DD65Y DE07Y DE10Y DE13Y ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 47/12 A61K 47/12 47/36 47/36 A61P 3/02 A61P 3/02 // B01F 17 / 38 B01F 17/38 17/56 17/56 F term (reference) 4B018 MD04 MD33 MD35 ME14 MF10 4C076 AA22 BB01 CC40 DD43F EE30F FF16 FF43 4C086 AA01 HA04 HA16 HA19 MA02 MA05 MA23 MA52 NA03 ZC21 4D077 AA02 CA08 DA05 DC26Y DC28Y DD65Y DE07Y DE10Y DE13Y
Claims (8)
類と、粒径500nm以下の水に難溶なカルシウム化合
物微粒子とを、重量比10:90〜99.9:0.1の
範囲で含有する多糖類/カルシウム化合物複合体を含有
することを特徴とするカルシウム補強剤。1. A polysaccharide containing a carboxyl group in a molecule and water-insoluble calcium compound fine particles having a particle size of 500 nm or less in a weight ratio of 10:90 to 99.9: 0.1. A calcium reinforcing agent comprising a polysaccharide / calcium compound complex.
類の水系媒体中に粒径500nm以下の水に難溶なカル
シウム化合物微粒子を分散してなる、分散安定性に優れ
る多糖類/カルシウム化合物複合体分散溶液を含有する
ことを特徴とする請求項1に記載のカルシウム補強剤。2. A polysaccharide / calcium compound composite having excellent dispersion stability, obtained by dispersing a water-insoluble calcium compound fine particle having a particle size of 500 nm or less in an aqueous medium of a polysaccharide containing a carboxyl group in the molecule. The calcium reinforcing agent according to claim 1, comprising a body dispersion solution.
シウムまたはリン酸カルシウムであることを特徴とする
請求項1または2に記載のカルシウム補強剤。3. The calcium reinforcing agent according to claim 1, wherein the calcium compound hardly soluble in water is calcium carbonate or calcium phosphate.
リン酸を反応して製造されるものであることを特徴とす
る請求項3に記載のカルシウム補強剤。4. The calcium reinforcing agent according to claim 3, wherein the calcium phosphate is produced by reacting calcium hydroxide and phosphoric acid.
ボキシル基を含有する多糖類存在下にカルシウム化合物
を製造して得られるものであることを特徴とする、請求
項1〜4のいずれかに記載のカルシウム補強剤。5. The polysaccharide / calcium compound complex is obtained by producing a calcium compound in the presence of a carboxyl group-containing polysaccharide. Calcium supplement.
に、カルシウム化合物を製造することを特徴とする、請
求項1〜4のいずれかに記載のカルシウム補強剤の製造
方法。6. The method for producing a calcium reinforcing agent according to claim 1, wherein the calcium compound is produced in the presence of a polysaccharide containing a carboxyl group.
m以下の水に難溶なカルシウム化合物微粒子を分散して
なる、分散安定性に優れるクエン酸塩/カルシウム化合
物複合体分散溶液を含有するものであって、該分散溶液
がクエン酸塩存在下にカルシウム化合物を製造して得ら
れるものであることを特徴とする、クエン酸塩/カルシ
ウム化合物複合体を含有するカルシウム補強剤。7. A particle size of 500 n in an aqueous medium of citrate.
m, which contains a citrate / calcium compound composite dispersion having excellent dispersion stability, which is obtained by dispersing calcium compound fine particles insoluble in water of not more than m. A calcium reinforcing agent containing a citrate / calcium compound complex, which is obtained by producing a calcium compound.
製造することを特徴とする、請求項7に記載のカルシウ
ム補強剤の製造方法。8. The method for producing a calcium reinforcing agent according to claim 7, wherein the calcium compound is produced in the presence of a citrate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000119045A JP2001299280A (en) | 2000-04-20 | 2000-04-20 | Calcium supplement including polysaccharide having carboxyl group and calcium-enriched agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000119045A JP2001299280A (en) | 2000-04-20 | 2000-04-20 | Calcium supplement including polysaccharide having carboxyl group and calcium-enriched agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001299280A true JP2001299280A (en) | 2001-10-30 |
Family
ID=18630091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000119045A Pending JP2001299280A (en) | 2000-04-20 | 2000-04-20 | Calcium supplement including polysaccharide having carboxyl group and calcium-enriched agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001299280A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007295830A (en) * | 2006-04-28 | 2007-11-15 | Asahi Kasei Pharma Kk | Fluid diet excellent in stability |
| JP2008099605A (en) * | 2006-10-19 | 2008-05-01 | Q P Corp | Sheet-like food composition and method for improving oral hygiene |
| CN100441103C (en) * | 2002-09-23 | 2008-12-10 | 甜糖(曼海姆/奥克森富特)股份公司 | coated chewing gum |
| JP2009527252A (en) * | 2006-02-21 | 2009-07-30 | ニュートリジョイ,インコーポレイテッド | Food and beverage products with improved taste impression |
| WO2021246373A1 (en) * | 2020-06-01 | 2021-12-09 | 株式会社トレスバイオ研究所 | Dispersion |
-
2000
- 2000-04-20 JP JP2000119045A patent/JP2001299280A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100441103C (en) * | 2002-09-23 | 2008-12-10 | 甜糖(曼海姆/奥克森富特)股份公司 | coated chewing gum |
| US8778425B2 (en) | 2002-09-23 | 2014-07-15 | Sudzucker Aktiengesellschaft Mannheim | Coated chewing gum |
| JP2009527252A (en) * | 2006-02-21 | 2009-07-30 | ニュートリジョイ,インコーポレイテッド | Food and beverage products with improved taste impression |
| JP2007295830A (en) * | 2006-04-28 | 2007-11-15 | Asahi Kasei Pharma Kk | Fluid diet excellent in stability |
| JP2008099605A (en) * | 2006-10-19 | 2008-05-01 | Q P Corp | Sheet-like food composition and method for improving oral hygiene |
| WO2021246373A1 (en) * | 2020-06-01 | 2021-12-09 | 株式会社トレスバイオ研究所 | Dispersion |
| JPWO2021246373A1 (en) * | 2020-06-01 | 2021-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5614243A (en) | Starch-based texturizing agents and method of manufacture | |
| CA2767773C (en) | Composition comprising a salt and a crystallization interrupter | |
| EP2668855A1 (en) | Method for producing a low sodium salt composition | |
| JP2000504229A (en) | Food fortification with calcium complex | |
| JP3076732B2 (en) | Calcium fortified beverage and method for producing the same | |
| JPH05260906A (en) | Aqueous calcium citrate composition | |
| US8501255B2 (en) | Particulate composition comprising calcium lactate and calcium citrate microparticles | |
| AU2009314886B2 (en) | Acidic soluble protein-containing beverage composition and method for producing same | |
| US20090238947A1 (en) | Calcium Fortified Food Product and Additive | |
| EP2120600B1 (en) | Particulate composition comprising calcium lactate and calcium citrate microparticles | |
| JP2001299280A (en) | Calcium supplement including polysaccharide having carboxyl group and calcium-enriched agent | |
| JP2008245622A (en) | Zinc-reinforced food and drink | |
| JP4066111B2 (en) | Water-insoluble or sparingly soluble mineral dispersion composition | |
| JP2766829B2 (en) | Partially gelled hydrophilic mannan paste-like food material and its production method | |
| JP2012231701A (en) | Kit for preparing acidic gel-like food | |
| JP4319902B2 (en) | Curdlan-containing material, production method thereof, and curdlan solution | |
| JP2018530339A (en) | Soluble calcium stabilized in anionic-cationic polymer and fructan | |
| JP3269595B2 (en) | Novel calcium agent having viscoelasticity and method for producing the same | |
| JP3878235B2 (en) | Method for producing stabilized calcium | |
| JP2012016325A (en) | Method for producing rice protein composition and food product | |
| JP3520295B2 (en) | Manufacturing method of salt | |
| KR20250155338A (en) | High-protein sauce and method for manufacturing high-protein sauce | |
| JPH09271331A (en) | Production of paste of sea algae and edible gel | |
| JP2002065209A (en) | New calcium agent having viscoelasticity and method for producing the same | |
| JP3405728B2 (en) | New calcium agent having viscoelasticity and method for producing the same |